Tianyin Pharmaceutical Co., Inc. (
FQ3 2011 Earnings Call
May 17, 2011 9:00 am ET
James Jiayuan Tong – Chief Financial Officer and Chief Business & Development Officer
Adam Waldo – Lismore Partners LLC
Angel Liu – Pope Asset Management
Iao Kiagra – Private Investor
Good morning ladies and gentlemen and thank you for standing by. Welcome to the Tianyin Pharmaceutical Incorporated FQ3 2011 Earnings Conference Call.
And at this time I would now like to turn the conference over to Dr. James Tong who is the Chief Financial Officer. Please go ahead sir.
James Jiayuan Tong
Thank you operator. Good morning, good evening ladies and gentlemen. Welcome to Tianyin Pharmaceutical TTI FQ3 2011 Earnings Conference Call. I am James Jiayuan Tong, Chief Financial Officer and Chief Business Development Officer of TTI along with Simon Min Ren, Director of Investor Relation and Meinian Yuan, Assistant to CFO. We haven’t connected with Dr. Guoqing, CEO and Chairman of the company because he is on the road at the moment and so far the signal connection has not been restored.
During this conference call we will be reviewing the FQ3 2011 financial highlights followed by the question and answer period. Before we continue please know that this call will contain forward-looking statements made under the Safe Harbor provisions of the US Private Security Litigation Reform Act of 1995.